SCH 530348

SCH-530348 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCH 530348, covering 2015-09-29 to 2015-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558) [Phase 1]